AIG
VERA icon

American International Group’s Vera Therapeutics VERA Stock Holding History

American International Group’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-19,764
Closed -$852K – 2625
2024
Q1 		$852K Buy
19,764
+2,957
+18% +$105K ﹤0.01% 1387
2023
Q4 		$258K Sell
16,807
-67
-0.4% -$851 ﹤0.01% 2032
2023
Q3 		$231K Buy
16,874
+599
+4% +$10.3K ﹤0.01% 2050
2023
Q2 		$261K Buy
16,275
+5,799
+55% +$52.4K ﹤0.01% 2019
2023
Q1 		$81.3K Buy
10,476
+3,698
+55% +$28.5K ﹤0.01% 2547
2022
Q4 		$131K Buy
6,778
+127
+2% +$2.3K ﹤0.01% 2379
2022
Q3 		$142K Buy
6,651
+163
+3% +$3.05K ﹤0.01% 2359
2022
Q2 		$88K Sell
6,488
-306
-5% -$5.34K ﹤0.01% 2678
2022
Q1 		$160K Buy
6,794
+1,535
+29% +$33K ﹤0.01% 2379
2021
Q4 		$141K Buy
5,259
+1,392
+36% +$30.8K ﹤0.01% 2559
2021
Q3 		$67K Buy
+3,867
New +$69.1K ﹤0.01% 2933

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

American International Group's VERA Position: Q2 2024 in Review

American International Group sold out of Vera Therapeutics (VERA) in Q2 2024, closing a stake of 19,764 shares — an estimated $852K sold.

American International Group first reported a position in VERA in Q3 2021 and held it in 11 quarters. The position peaked at $852K in Q1 2024. 171 funds tracked by Wall St. Rank hold VERA as of Q2 2024.

  • American International Group reported no remaining Vera Therapeutics position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 19,764 Vera Therapeutics shares in Q2 2024, an estimated $852K.
  • American International Group first reported a position in Vera Therapeutics in Q3 2021 and held it in 11 quarters.
  • American International Group's Vera Therapeutics position peaked at $852K in Q1 2024.
  • 171 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.